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Roles of the sympathetic nervous system versus kidney salt transporters in hypertension are debated.
A study in Nature Medicine (Mu et al., 2011) shows that dietary salt excess, coupled with b-adrenergic
stimulation, increases arterial pressure via glucocorticoid receptors and WNK4, suggesting interactions
between these systems in the pathogenesis of hypertension.Hypertension affects 1.5 billion people
worldwide and is the single largest risk
factor for premature mortality (Lopez
et al., 2006). Arterial pressure is, simply,
the product of cardiac output and sys-
temic vascular resistance, suggesting that
causes of hypertension should be obvi-
ous. Still, two seemingly independent
schools of thought dominate the current
debate. Specifically, hypertension is often
viewed as resulting from either overac-
tivity of the sympathetic nervous system
(Osborn et al., 2009) or from excessive
kidney salt reabsorption (Montani and
Van Vliet, 2009). In their recent study in
Nature Medicine (Mu et al., 2011), Mu
and colleagues provide evidence for a
novel pathogenic model for human hyper-
tension that synthesizes the effects of the
renal and nervous systems.
High levels of salt (NaCl) consumption
cause hypertension in some individuals
(defining them as salt sensitive), whereas
other individuals are protected from such
effects. Salt-sensitive individuals exhibit
neurohormonal responses to dietary salt
intake that differ from those who are re-
sistant, but the underlying mechanisms
remain unclear. In their recent study in
Nature Medicine, Mu and colleagues (Mu
et al., 2011) describe intriguing links
between sympathetic overactivity, gluco-
corticoid receptor (GR) stimulation,WNK4
suppression, and thiazide-sensitive Na-Cl
cotransporter (NCC) activation.
These investigators show that chronic
stimulation of b-adrenergic receptors,
coupled with dietary salt excess, induces
hypertension in mice; as shown schemat-
ically in Figure 1, they found that hyper-tension was associated with increases in
the abundance and activity of NCC and
with a decrease in the regulatory kinase,
WNK4. Interestingly, the investigators
also found that GR binding was essential
for this effect, as treatment of mice with
a GR antagonist, or adrenalectomy, abol-
ished the effects of isoproterenol and salt
loading on WNK4. Furthermore, genetic
deletion of GR from the distal nephron
prevented the hypertensive effects of salt
loading and isoproterenol. This require-
ment for GR occupancy in the nephron
resembles the well-recognized require-
ment of GR occupancy for sympathetic
vasoconstriction, systemically.
Their results suggest a key role for GR
in mediating the effects of sympathetic
activity on NCC. While aldosterone is
well recognized for its role in regulating
distal Na transport, glucocorticoids are
not as widely recognized for playing an
essential role. Yet dexamethasone and
aldosterone have been shown to stimu-
late NCC independently. A gradient of
steroid hormone selectivity has been sug-
gested to be present along the distal
convoluted tubule (DCT) (Figure 1), with
more proximal segments sensitive to glu-
cocorticoids and more distal segments to
aldosterone (Reilly and Ellison, 2000). The
differential sensitivity results from the
graded abundance of 11 b-OH steroid
dehydrogenase 2 along the distal nephron
(Reilly and Ellison, 2000); this enzyme
metabolizes glucocorticoid hormones,
leaving aldosterone to bind to mineralo-
corticoid receptors. The results of Mu and
colleagues (Mu et al., 2011) suggest that
sympathetic stimulation of NCC mightCell Metabolismoccur predominantly along proximal,
glucocorticoid-sensitive segments of the
DCT, whereas aldosterone stimulation
would be predominantly distal.
This study also found that steroid
hormones interact with WNK kinases to
regulate NaCl transport (Mu et al., 2011).
The investigators demonstrated that iso-
proterenol increased histone acetylation
near glucocorticoid response elements
(GREs) within the promoter of WNK4.
Isoproterenol therefore reduced WNK4
transcription, an effect postulated to stim-
ulate NCC. This work supports the view
that, at least under some conditions,
WNK4 inhibits NCC (Yang et al., 2003),
and that sympathetic nerve activity raises
arterial pressure partly by activating NCC.
Yet the precise role of WNK4 in activating
NaCl transport in this studywas not tested
directly (Mu et al., 2011). WNK4 activity
can switch from inhibitory to stimulatory
during human disease or when activated
by angiotensin II (McCormick and Ellison,
2011); thus, a clear view of WNK4’s role in
b-adrenergic stimulation of NCC requires
further work.
The results of this study raise other
important questions. b-adrenergic recep-
tor activation also increases plasma renin
activity. Does isoproterenol infusion (in
the context of a high-salt diet) decrease
WNK4 and increase NCC in part because
of relative increases in renal angiotensin
II?Althoughangiotensin receptorblockers
(ARBs) did not prevent hypertension in this
setting, plasma renin activity or renal
renin/angiotensin II levels were not mea-
sured, and a role for angiotensin II was
not excluded. In addition, while the focus13, June 8, 2011 ª2011 Elsevier Inc. 619
Figure 1. Interactions between the Brain and Kidney in Hypertension
Mu and colleagues (Mu et al., 2011) show that sympathetic nerve activity, acting through b-adrenergic
receptors (bAR), in cooperation with glucocorticoid receptors (GR), suppresses WNK4 abundance and
activates the sodium chloride cotransporter (NCC) to raise arterial pressure. The inset shows the distal
nephron, with distal convoluted tubule (DCT, segments 1 and 2) and connecting tubules (CNT), expressing
the NCC, the epithelial Na channel (ENaC), mineralocorticoid receptors (MR), and 11 b-hydroxysteroid
dehydrogenase 2 (11 b-HSD). Note the gradation of 11 b-HSD abundance, conferring steroid specificity.
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Previewsof this study was on b-adrenergic stimula-
tion of renal NaCl reabsorption, how does
their proposed effect of increased renal
sympathetic nerve activity interact with
the well-known actions of renal a-recep-
tors to enhance salt retention (DiBona
and Kopp, 1997)?
Nevertheless, while previous studies
have hinted at a potential role for renal
b-adrenergic receptors in the control of
NaCl reabsorption (DiBona and Kopp,620 Cell Metabolism 13, June 8, 2011 ª20111997), this study (Mu et al., 2011) sug-
gests this action of renal sympathetic
nerves should receive greater attention.
b-receptor antagonists have been used
for decades to treat hypertension, yet
their mechanism of action is incompletely
understood. Is it possible that this previ-
ously unappreciated role of renal b-adren-
ergic receptors on urinary sodium excre-
tion, and therefore long-term control of
blood pressure, contributes?Elsevier Inc.Finally, this study reiterates the view
that sympathetic nervous stimulation
and renal salt transport are usually stimu-
lated concurrently and converge on com-
mon mechanisms (in this case, steroid
hormones and WNK4). There is emerging
interest in device-based approaches to
resistant hypertension, some of which
ablate renal sympathetic nerves (Krum
et al., 2011). The results of the study by
Mu and colleagues (Mu et al., 2011)
suggest that such devises reduce blood
pressure, in part, by activating WNK4
and inhibiting NCC. As NCC can be de-
tected in urinary exosomes (Joo et al.,
2007), it should be possible to test this
hypothesis directly in humans.REFERENCES
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